InvestmentPitch Media Video Discusses LOVE Pharma’s Plans to Continue Developing a Portfolio of Innovative Products such as Naltrexone Encompassing Transdermal Drug Delivery Applications for Addictions and Long-COVID
November 07, 2022 06:00 ET
|
InvestmentPitch Media and Love Pharma Inc
VANCOUVER, British Columbia, Nov. 07, 2022 (GLOBE NEWSWIRE) -- LOVE Pharma (CSE:LUV) (FSE:G1Q0) continues with its plans to develop a portfolio of innovative products encompassing transdermal drug...
InvestmentPitch Media Video Discusses Resverlogix and its Focus on Apabetalone’s Future Development for the Prevention and Treatment of Post COVID-19 Conditions
September 30, 2022 06:00 ET
|
InvestmentPitch Media and Resverlogix Corp.
VANCOUVER, British Columbia, Sept. 30, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. (TSX:RVX) (OTCPink:RVXCF), a world leader in epigenetics, or gene regulation, announced that apabetalone’s future...
Employer-Reported Respiratory Illness Increased 4,000% in 2020, Signaling Effects from COVID-19, Allsup Reports
March 21, 2022 16:58 ET
|
Allsup
Belleville, Illinois, March 21, 2022 (GLOBE NEWSWIRE) -- Employer-reported respiratory illnesses among U.S. workers increased nearly 4,000% in 2020, signaling effects from the pandemic, according to...